Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson’s disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson’s disease
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROLOGY
Volume 20, Issue 1, Pages 50-56
Publisher
Wiley
Online
2012-04-27
DOI
10.1111/j.1468-1331.2012.03712.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Conversion from Twice-daily to Once-daily Tacrolimus in a Large Cohort of Stable Kidney Transplant Recipients
- (2011) L. Guirado et al. AMERICAN JOURNAL OF TRANSPLANTATION
- An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence
- (2011) Aribert Rothenberger et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease
- (2011) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial
- (2011) W. Poewe et al. NEUROLOGY
- Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial
- (2011) A. H. V. Schapira et al. NEUROLOGY
- Prevalence and cost of medication nonadherence in Parkinson's disease: Evidence from administrative claims data
- (2010) Keith L. Davis et al. MOVEMENT DISORDERS
- Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
- (2010) Robert A. Hauser et al. MOVEMENT DISORDERS
- Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations
- (2010) Bonnie P. Hersh et al. MOVEMENT DISORDERS
- Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study
- (2010) David Price et al. BMC Pulmonary Medicine
- Challenges of Treatment Adherence in Older Patients with Parkinson’s Disease
- (2009) Jacquelyn L Bainbridge et al. DRUGS & AGING
- Adherence to antiparkinson medication in a multicenter European study
- (2009) Donald Grosset et al. MOVEMENT DISORDERS
- Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study
- (2008) Fabrizio Stocchi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Randomization to Once-Daily Stavudine Extended Release/Lamivudine/Efavirenz Versus a More Frequent Regimen Improves Adherence While Maintaining Viral Suppression
- (2008) Brian A. Boyle et al. HIV CLINICAL TRIALS
- Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease
- (2007) Amit S. Kulkarni et al. MOVEMENT DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now